Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 5
1991 1
1995 1
1997 1
2006 3
2007 6
2008 14
2009 17
2010 30
2011 39
2012 43
2013 50
2014 51
2015 49
2016 38
2017 40
2018 39
2019 28
2020 39
2021 22
Text availability
Article attribute
Article type
Publication date

Search Results

457 results
Results by year
Filters applied: . Clear all
Page 1
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.
Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Bond DJ, Frey BN, Sharma V, Goldstein BI, Rej S, Beaulieu S, Alda M, MacQueen G, Milev RV, Ravindran A, O'Donovan C, McIntosh D, Lam RW, Vazquez G, Kapczinski F, McIntyre RS, Kozicky J, Kanba S, Lafer B, Suppes T, Calabrese JR, Vieta E, Malhi G, Post RM, Berk M. Yatham LN, et al. Bipolar Disord. 2018 Mar;20(2):97-170. doi: 10.1111/bdi.12609. Epub 2018 Mar 14. Bipolar Disord. 2018. PMID: 29536616 Free PMC article.
Created by considering the impact of each treatment across all phases of illness, this hierarchy will further assist clinicians in making evidence-based treatment decisions. Lithium, quetiapine, divalproex, asenapine, aripiprazole, paliperidone, risperidone, and cariprazin …
Created by considering the impact of each treatment across all phases of illness, this hierarchy will further assist clinicians in making ev …
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis.
Leucht S, Cipriani A, Spineli L, Mavridis D, Orey D, Richter F, Samara M, Barbui C, Engel RR, Geddes JR, Kissling W, Stapf MP, Lässig B, Salanti G, Davis JM. Leucht S, et al. Lancet. 2013 Sep 14;382(9896):951-62. doi: 10.1016/S0140-6736(13)60733-3. Epub 2013 Jun 27. Lancet. 2013. PMID: 23810019 Review.
METHODS: We did a Bayesian-framework, multiple-treatments meta-analysis (which uses both direct and indirect comparisons) of randomised controlled trials to compare 15 antipsychotic drugs and placebo in the acute treatment of schizophrenia. We searched the Cochrane Schizophrenia …
METHODS: We did a Bayesian-framework, multiple-treatments meta-analysis (which uses both direct and indirect comparisons) of randomised cont …
Dose-Response Meta-Analysis of Antipsychotic Drugs for Acute Schizophrenia.
Leucht S, Crippa A, Siafis S, Patel MX, Orsini N, Davis JM. Leucht S, et al. Am J Psychiatry. 2020 Apr 1;177(4):342-353. doi: 10.1176/appi.ajp.2019.19010034. Epub 2019 Dec 16. Am J Psychiatry. 2020. PMID: 31838873
The 95% effective doses and the doses equivalent to 1 mg of oral risperidone, respectively, were as follows: amisulpride for patients with positive symptoms, 537 mg/day and 85.8 mg; aripiprazole, 11.5 mg/day and 1.8 mg; aripiprazole LAI (lauroxil), 463 mg every 4 weeks and 264 mg …
The 95% effective doses and the doses equivalent to 1 mg of oral risperidone, respectively, were as follows: amisulpride for patients with p …
Clinical Pharmacokinetics of Atypical Antipsychotics: An Update.
Mauri MC, Paletta S, Di Pace C, Reggiori A, Cirnigliaro G, Valli I, Altamura AC. Mauri MC, et al. Clin Pharmacokinet. 2018 Dec;57(12):1493-1528. doi: 10.1007/s40262-018-0664-3. Clin Pharmacokinet. 2018. PMID: 29915922 Review.
This review concentrates on the clinical pharmacokinetic data related to clozapine, risperidone, paliperidone, olanzapine, quetiapine, amisulpride, ziprasidone, aripiprazole, sertindole, asenapine, iloperidone, lurasidone, brexpiprazole and cariprazine and briefly consider …
This review concentrates on the clinical pharmacokinetic data related to clozapine, risperidone, paliperidone, olanzapine, quetiapine, amisu …
Treatments for Schizophrenia in Adults: A Systematic Review [Internet].
McDonagh MS, Dana T, Selph S, Devine EB, Cantor A, Bougatsos C, Blazina I, Grusing S, Fu R, Kopelovich SL, Monroe-DeVita M, Haupt DW. McDonagh MS, et al. Rockville (MD): Agency for Healthcare Research and Quality (US); 2017 Oct. Report No.: 17(18)-EHC031-EF. Rockville (MD): Agency for Healthcare Research and Quality (US); 2017 Oct. Report No.: 17(18)-EHC031-EF. PMID: 29537779 Free Books & Documents. Review.
For drug therapy, the majority of the head-to-head evidence was on older SGAs, with sparse data on SGAs approved in the last 10 years (asenapine, lurasidone, iloperidone, cariprazine, brexpiprazole) and recent long-acting injection (LAI) formulations of aripiprazole and pa …
For drug therapy, the majority of the head-to-head evidence was on older SGAs, with sparse data on SGAs approved in the last 10 years (as
Treatment for Bipolar Disorder in Adults: A Systematic Review [Internet].
Butler M, Urosevic S, Desai P, Sponheim SR, Popp J, Nelson VA, Thao V, Sunderlin B. Butler M, et al. Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Aug. Report No.: 18-EHC012-EF. Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Aug. Report No.: 18-EHC012-EF. PMID: 30329241 Free Books & Documents. Review.
All drug study findings with at least low-strength evidence were based almost exclusively on adults with bipolar I disorder (BD-I). Asenapine, cariprazine, quetiapine, and olanzapine improved acute mania symptoms compared to placebo (low-strength evidence). ...
All drug study findings with at least low-strength evidence were based almost exclusively on adults with bipolar I disorder (BD-I). Asena
A History of the Pharmacological Treatment of Bipolar Disorder.
López-Muñoz F, Shen WW, D'Ocon P, Romero A, Álamo C. López-Muñoz F, et al. Int J Mol Sci. 2018 Jul 23;19(7):2143. doi: 10.3390/ijms19072143. Int J Mol Sci. 2018. PMID: 30041458 Free PMC article. Review.
In this paper, the authors review the history of the pharmacological treatment of bipolar disorder, from the first nonspecific sedative agents introduced in the 19th and early 20th century, such as solanaceae alkaloids, bromides and barbiturates, to John Cade's experiments …
In this paper, the authors review the history of the pharmacological treatment of bipolar disorder, from the first nonspecific sedative agen …
Weight gain and antipsychotics: a drug safety review.
Musil R, Obermeier M, Russ P, Hamerle M. Musil R, et al. Expert Opin Drug Saf. 2015 Jan;14(1):73-96. doi: 10.1517/14740338.2015.974549. Epub 2014 Nov 15. Expert Opin Drug Saf. 2015. PMID: 25400109 Review.
EXPERT OPINION: Recently published data still support the hierarchical ranking of SGAs already proposed in previous reviews ranking clozapine and olanzapine as having the highest risk, followed by amisulpride, asenapine, iloperidone, paliperidone, quetiapine, risperidone a …
EXPERT OPINION: Recently published data still support the hierarchical ranking of SGAs already proposed in previous reviews ranking clozapin …
A Review of Asenapine in the Treatment of Bipolar Disorder.
Vieta E, Montes JM. Vieta E, et al. Clin Drug Investig. 2018 Feb;38(2):87-99. doi: 10.1007/s40261-017-0592-2. Clin Drug Investig. 2018. PMID: 29067671 Free PMC article. Review.
It is the antagonistic activity at the D(2) receptor that is likely responsible for the antimanic properties of asenapine. Clinical trials have demonstrated that asenapine mono- and add-on therapy is effective in the short- and long-term treatment of mania associate …
It is the antagonistic activity at the D(2) receptor that is likely responsible for the antimanic properties of asenapine. Clinical t …
Lumateperone (Caplyta) for schizophrenia.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2020 Jul 27;62(1603):113-116. Med Lett Drugs Ther. 2020. PMID: 32728011 Review. No abstract available.
457 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page